Taichung, Taiwan

Min-Tsang Hsieh



 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2020

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Min-Tsang Hsieh: Innovator in Anticancer Research

Introduction

Min-Tsang Hsieh is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of anticancer research, holding a total of three patents. His work focuses on developing novel compounds that show promise in treating various types of cancer.

Latest Patents

One of his latest patents involves derivatives of curcuminoids and their use as anticancer agents. This series of novel bis(hydroxymethyl) alkanoate derivatives of curcuminoids has demonstrated anticancer activity, particularly against breast cancer, colon cancer, and prostate cancer. Another notable patent relates to novel 20-sulfonylamidine derivatives of camptothecin, which includes methods of synthesizing these compounds and their application as antitumor agents for treating nasopharyngeal, lung, breast, or prostate cancer.

Career Highlights

Min-Tsang Hsieh has worked at China Medical University and China Medical University Hospital, where he has contributed to various research initiatives. His innovative approaches in the laboratory have led to advancements in cancer treatment methodologies.

Collaborations

Throughout his career, Hsieh has collaborated with notable colleagues, including Sheng-Chu Kuo and Ling-Chu Chang. These partnerships have fostered a collaborative environment that enhances research outcomes.

Conclusion

Min-Tsang Hsieh's work in developing anticancer agents showcases his dedication to improving cancer treatment options. His innovative patents and collaborations highlight his significant role in the field of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…